The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
mTOR is a key modulator of ageing and age-related disease
Open accessAbstract
Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the mammalian target of rapamycin (mTOR) pathway, which is induced by amino acids, growth factors, and RT, is often inhibited during CR, and mediates CR-induced health benefits in model organisms [37].”
From Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a well-known inhibitor of mTOR, rapamycin, inhibits the production of SASP factors”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which might explain its beneficial impact on longevity [121,122].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic down-regulation of mTORC1 activity in yeast, worms and flies extends longevity and attenuates further longevity benefits from DR, suggesting that mTOR inhibition phenocopies DR”
From The Hallmarks of Aging (2013) · cites this paper as Johnson et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inhibition of mTOR has been shown to extend lifespan and to improve the function of ageing organ systems, including the immune system, in multiple preclinical species.18, 19”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“One of the best validated mechanisms underlying ageing biology is the activity of the protein kinase mTOR.”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“More importantly, these pathways have been evaluated in mammalian models, in which health span and lifespan have been extended by genetic manipulation or drugs (Johnson et al., 2013).”
From Metformin as a tool to target aging (2016) · cites this paper as Johnson et al., 2013
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Based on previous studies in the aging field, it is believed that Nrf2 is repressed by mTOR pathway (downstream target); therefore, an inhibition of mTOR by rapamycin would increase the activity of Nrf2 (Johnson et al., 2013).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Johnson et al., 2013
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Aging, natural death, and the compression of morbidity
Fries, J. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030304 · Cited by 3,356
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,006
Metformin delays satellite cell activation and maintains quiescence
Pavlidou, T., Marinkovic, M., Rosina, M., Fuoco, C., Vumbaca, S., Gargioli, C., Castagnoli, L., & Cesareni, G. (2019) · Stem Cells International · doi:10.1155/2019/5980465 · Cited by 38
“These findings highlight a possible use of metformin as a pharmacological intervention for muscle stem cell maintenance during the repeated regeneration cycles in disease [49, 50] or in aging, when chronic activation of mTOR signaling occurs [51, 52].”
BackgroundGao, D., Wang, S., Lin, Y., & Sun, Z. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101692 · Cited by 39
Aryl hydrocarbon receptor (AhR) impairs circadian regulation: Impact on the aging process
Salminen, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101928 · Cited by 42
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging
Noll, J. H., Levine, B. L., June, C. H., & Fraietta, J. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101840 · Cited by 41
Arlia‐Ciommo, A., Piano, A., Leonov, A., Svistkova, V., & Titorenko, V. I. (2014) · Cell Cycle · doi:10.4161/15384101.2014.965063 · Cited by 39
Concise Review: Hematopoietic Stem Cell Aging and the Prospects for Rejuvenation
Wahlestedt, M., Pronk, C. J., & Bryder, D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0132 · Cited by 38
Mutations of RagA GTPase in mTORC1 Pathway Are Associated with Autosomal Dominant Cataracts
Chen, J., Huang, C., Zhang, B. N., Yin, S., Liang, J., Xu, C., Huang, Y., Cen, L., Ng, T. K., Zheng, C., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006090 · Cited by 38
Targeting Autophagy as a Strategy for Drug Discovery and Therapeutic Modulation
Gao, L., Jauregui, C. E., & Teng, Y. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0210 · Cited by 39
Lewis, K. N., & Buffenstein, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00006-x · Cited by 42
Calorie Restriction-Regulated Molecular Pathways and Its Impact on Various Age Groups: An Overview
Rachakatla, A., & Kalashikam, R. R. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.0922 · Cited by 37
“Many anabolic processes are reduced due to the inhibition of mTOR and S6K1 by AMPK (Johnson et al. , 2013). mTOR inhibition and AMPK activation shows catabolic process called autophagy by the activation of Unc-51-like autophagy-activating kinase 1 (Ulk1 complex) under CR. Ulk1 complex along with…”
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention
O’Shea, A. E., Valdera, F. A., Ensley, D. C., Smolinsky, T. R., Cindass, J. L., Bohan, P. M. K., Hickerson, A. T., Carpenter, E. L., McCarthy, P. M., Adams, A. M., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109095 · Cited by 40
Physiological Systems in Promoting Frailty
Perazza, L. R., Brown‐Borg, H. M., & Thompson, L. V. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210034 · Cited by 69
“Indeed, in a range of animal models, mTOR is a key modulator of lifespan and healthspan acting through various mechanisms (227, 270, 387, 388).”
The Current Landscape of Pharmacotherapies for Sarcopenia
Bahat, G., & Özkök, S. (2024) · Drugs & Aging · doi:10.1007/s40266-023-01093-7 · Cited by 41
“Moreover, reduced mTOR signaling has been linked to longevity, shown to reduce age-related pathologies in model organisms (and in some human studies), and may have similar beneficial effects on age-related sarcopenia [21, 39].”
Chandler-Brown, D. B., Choi, H., Park, S., Ocampo, B. R., Chen, S., Le, A., Sutphin, G. L., Shamieh, L. S., Smith, E. D., & Kaeberlein, M. R. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00316 · Cited by 40
Wu, J., Huang, J., Khanabdali, R., Kalionis, B., Xia, S., & Cai, W. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.04.008 · Cited by 37
mTOR Inhibition Rejuvenates the Aging Gingival Fibroblasts through Alleviating Oxidative Stress
Xia, Y., Sun, M., Xie, Y., & Shu, R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6292630 · Cited by 39
“mTOR signaling is triggered by various environmental stimuli and modulates several known longevity factors in a complex signaling network including an insulin/IGF-1-like axis [12].”
BackgroundBarnes, P. J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_3 · Cited by 37
mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis
Hiraiwa, M., Ozaki, K., Yamada, T., Iezaki, T., Park, G., Fukasawa, K., Horie, T., Kamada, H., Tokumura, K., Motono, M., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00684 · Cited by 37
Recent Advances in Anti-Aging Medicine
Son, D., Park, W.-J., & Lee, Y. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.19.0087 · Cited by 38
Miller, B. F., Pharaoh, G. A., Hamilton, K. L., Peelor, F. F., Kirkland, J. L., Freeman, W. M., Mann, S. N., Kinter, M. T., Price, J. C., & Stout, M. B. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz113 · Cited by 37
“These observations were also associated with changes in WAT AMPKα and mTORC1 signaling, which are consistent with beneficial metabolic outcomes with advancing age (8,9).”
BackgroundAsymmetric cell division shapes naive and virtual memory T-cell immunity during ageing
Borsa, M., Barandun, N., Gräbnitz, F., Barnstorf, I., Baumann, N. S., Pallmer, K., Baumann, S., Stark, D., Baláž, M., Oetiker, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22954-y · Cited by 37
Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy
Jeda, A. S., Ghabeshi, S., pour, Z. G. M., Jazaeri, E. O., Araiinejad, M., Sheikholeslami, F., Abdoli, M., Edalat, M., & Abdoli, A. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100512 · Cited by 38
Tricarboxylic Acid Cycle Intermediates and Individual Ageing
Kurhaluk, N. (2024) · Biomolecules · doi:10.3390/biom14030260 · Cited by 39
“…and the mTOR as the main target and sestrin are related to the concepts that metabolic interventions deplete acetate stores and probably reduce the conversion of oxaloacetate to aspartate, thereby inhibiting the mammalian target of the rapamycin (mTOR) pathway and enhancing autophagy [54].”
BackgroundmTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
Zou, Z., Chen, J., Liu, A., Zhou, X., Song, Q., Jia, C., Chen, Z., Lin, J., Yang, C., Li, M., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201411128 · Cited by 36
Deivasigamani, S., Verma, H., Ueda, R., Ratnaparkhi, A., & Ratnaparkhi, G. S. (2014) · Biology Open · doi:10.1242/bio.201410066 · Cited by 33
Yuan, J., Zhao, X., Hu, Y., Sun, H., Gong, G., Huang, X., Chen, X., Xia, M., Sun, C., Huang, Q., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3393 · Cited by 36
Zhang, J., Zhou, Q., Chen, S., & Le, W. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12855 · Cited by 36
Du, G., Liu, Z., Yu, Z., Zhuo, Z., Zhu, Y., Zhou, J., Yang, L., & Chen, H. (2021) · Aging Cell · doi:10.1111/acel.13319 · Cited by 38
“Several signaling pathways, such as c- Jun N- terminal kinase (JNK) (Biteau et al., 2008), mTOR (Johnson et al., 2013), and ROS (Chen et al., 2017), are involved in these agingassociated alterations.”
BackgroundThe Autophagy Inducer Spermidine Protects Against Metabolic Dysfunction During Overnutrition
Liao, C., Kummert, O. M. P., Bair, A. M., Alavi, N., Alavi, J., Miller, D. M., Bagga, I., Schempf, A. M., Hsu, Y.-M., Woods, B. D., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab145 · Cited by 34
Anti-Aging Drugs and the Related Signal Pathways
Du, N., Ruigang, Y., Jiang, S., Niu, Z., Zhou, W., Liu, C., Gao, L., & Sun, Q. (2024) · Biomedicines · doi:10.3390/biomedicines12010127 · Cited by 40
Kadakkuzha, B. M., Akhmedov, K., Capo, T., Carvalloza, A. C., Fallahi, M., & Puthanveettil, S. V. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-880 · Cited by 34
Preserving Youth: Does Rapamycin Deliver?
Johnson, S. C., Martin, G. M., Rabinovitch, P. S., & Kaeberlein, M. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007316 · Cited by 35
Gene expression patterns underlying parasite‐induced alterations in host behaviour and life history
Feldmeyer, B., Mazur, J., Beros, S., Lerp, H., Binder, H., & Foitzik, S. (2015) · Molecular Ecology · doi:10.1111/mec.13498 · Cited by 36
The role of DNA ‐ PK in aging and energy metabolism
Chung, J. H. (2018) · FEBS Journal · doi:10.1111/febs.14410 · Cited by 34
Neuroprotective Effect of Dioscin on the Aging Brain
Qi, Y., Li, R., Xu, L., Yin, L., Xu, Y., Han, X., & Peng, J. (2019) · Molecules · doi:10.3390/molecules24071247 · Cited by 37
Soo, S. K., Rudich, P. D., Traa, A., Harris-Gauthier, N., Shields, H. J., & Raamsdonk, J. M. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111297 · Cited by 37
Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction
Geng, X., Wang, F., Tian, D., Huang, L., Streator, E. S., Zhu, J., Kurihara, H., He, R., Yao, X., Zhang, Y., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114226 · Cited by 36
Sestrin family – the stem controlling healthy ageing
Haidurov, A., & Budanov, A. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111379 · Cited by 38
Thyroid Hormones Enhance Mitochondrial Function in Human Epidermis
Vidali, S., Chéret, J., Giesen, M., Haeger, S., Alam, M. A., Watson, R. E. B., Langton, A. K., Klinger, M. H. F., Knuever, J., Funk, W., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.118 · Cited by 35
Aging, metabolism and stem cells: Spotlight on muscle stem cells
García-Prat, L., & Muñoz-Cánoves, P. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.021 · Cited by 34
Genotype and Trait Specific Responses to Rapamycin Intake in Drosophila melanogaster
Rohde, P. D., Bøcker, A., Jensen, C. A. B., Bergstrøm, A. L., Madsen, M. I. J., Christensen, S. L., Villadsen, S. B., & Kristensen, T. N. (2021) · Insects · doi:10.3390/insects12050474 · Cited by 30
“Rapamycin constitutes an example of a drug that has been suggested to counteract many of the symptoms associated with age-related illnesses, such as Alzheimer’s disease, and reduced cognitive abilities [4,17].”
BackgroundRapamycin for longevity: the pros, the cons, and future perspectives
Roark, K. M., & Iffland, P. H. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1628187 · Cited by 37
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Reverse Expression of Aging-Associated Molecules through Transfection of miRNAs to Aged Mice
Kim, J., Lee, B., Choi, E., Lee, K., Choi, S., Cho, J. H., Jeon, W. B., & Kim, E. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.11.005 · Cited by 34
Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules
Heiß, C., Spyridopoulos, I., & Haendeler, J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.015 · Cited by 36
The role of lipids in aging-related metabolic changes
de Diego, I., Peleg, S., & Fuchs, B. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.05.005 · Cited by 35
Gómez‐Linton, D. R., Alavez, S., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., Königsberg, M., & Pérez-Flores, L. J. (2019) · Biogerontology · doi:10.1007/s10522-019-09817-2 · Cited by 34
HSF1 physically neutralizes amyloid oligomers to empower overgrowth and bestow neuroprotection
Tang, Z., Su, K., Xu, M., & Dai, C. (2020) · Science Advances · doi:10.1126/sciadv.abc6871 · Cited by 34
“Moreover, PI3K/ AKT/mTORC1 signaling, closely implicated in aging and age-related diseases ( 51 ), is hyperactivated in AD brains (Fig.”
Hearn, J., Plenderleith, F. A., & Little, T. J. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00379-z · Cited by 33
Rodríguez‐Mañas, L., Angulo, J., Carnicero, J. A. C., Assar, M. E., García‐García, F. J., & Sinclair, A. J. (2021) · GeroScience · doi:10.1007/s11357-021-00384-4 · Cited by 35
Kadry, H., Noorani, B., Bickel, U., Abbruscato, T. J., & Cucullo, L. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00261-4 · Cited by 36
“Metformin exerts its action through AMPK dependent and independent pathways [34, 40, 41].”
BackgroundShaerzadeh, F., Motamedi, F., & Khodagholi, F. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0099-9 · Cited by 36
Hong, B., Bea, S., Ko, H. Y., Kim, W. J., Cho, Y. M., & Shin, J.-Y. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3220 · Cited by 33
Therapeutic Potential of Extracellular Vesicles in Aging and Age-Related Diseases
Sanz‐Ros, J., Mas‐Bargues, C., Romero-García, N., Huete-Acevedo, J., Dromant, M., & Borrás, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314632 · Cited by 35
The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss
Ege, T., Tao, L., & North, B. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179705 · Cited by 39
“Rapamycin has been found to extend lifespan in rodents [183,184] and delays age-related dysfunction in rodents and humans [185].”
BackgroundMethods for the discovery of new anti-aging products – targeted approaches
Manayi, A., Saeidnia, S., Gohari, A. R., & Abdollahi, M. R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.885014 · Cited by 32
mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels
Goudarzi, K. M., Nistér, M., & Lindström, M. S. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.955743 · Cited by 35
DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling
Gharibi, B., Ghuman, M. S., & Hughes, F. J. (2016) · Scientific Reports · doi:10.1038/srep36889 · Cited by 35
Zhang, H.-M., Diaz, V., Walsh, M. E., & Zhang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00970-7 · Cited by 31
Beyond regulation of pol III: Role of MAF1 in growth, metabolism, aging and cancer
Zhang, S., Li, X., Wang, H., & Zheng, X. F. S. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.01.019 · Cited by 34
Genetic cartography of longevity in humans and mice: Current landscape and horizons
Hook, M., Roy, S., Williams, E. G., Sleiman, M. S. B., Mozhui, K., Nelson, J. F., Lu, L., Auwerx, J. H., & Williams, R. W. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.026 · Cited by 33
Age-dependent decline in stress response capacity revealed by proteins dynamics analysis
Chen, K., Shen, W., Zhang, Z., Xiong, F., Ouyang, Q., & Luo, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-72167-4 · Cited by 34
Chemical and Structural Strategies to Selectively Target mTOR Kinase
Borsari, C., Pascale, M. D., & Wymann, M. P. (2021) · ChemMedChem · doi:10.1002/cmdc.202100332 · Cited by 33
Complement factor B in high glucose–induced podocyte injury and diabetic kidney disease
Lu, Q., Hou, Q., Cao, K., Sun, X., Liang, Y., Gu, M., Xue, X., Zhao, A. Z., & Dai, C. (2021) · JCI Insight · doi:10.1172/jci.insight.147716 · Cited by 32
Mechanistic Target of Rapamycin (mTOR) Inhibitors
Wang, D., & Eisen, H. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_553 · Cited by 33
Cellular enlargement - A new hallmark of aging?
Davies, D., van den Handel, K., Bharadwaj, S., & Lengefeld, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036602 · Cited by 32
“Preventing this enlargement with drugs preserves their replicative age (Johnson et al., 2013; Neurohr et al., 2019).”
BackgroundLind, M. I., Zwoinska, M. K., Meurling, S., Carlsson, H., & Maklakov, A. A. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv174 · Cited by 33
Insights Into the Links Between Proteostasis and Aging From C. elegans
Zhang, W., Koyuncu, S., & Vílchez, D. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.854157 · Cited by 33
“1 The Mechanistic Target of Rapamycin Pathway One of the most crucial, and rate limiting, steps of translation is the initiation of translation by the mTOR pathway (Johnson et al., 2013).”
BackgroundAccumulation of F-actin drives brain aging and limits healthspan in Drosophila
Schmid, E. T., Schinaman, J. M., Liu-Abramowicz, N., Williams, K. S., & Walker, D. W. (2024) · Nature Communications · doi:10.1038/s41467-024-53389-w · Cited by 35
“Flies undergoing dietary restriction or treated with rapamycin,twoevolutionarilyconservedapproachestolifespanextension 38,39 , both show a reduction in F-actin in aged brains.”
Rejuvenating immunity: “anti-aging drug today” eight years later
Blagosklonny, M. V. (2015) · Oncotarget · doi:10.18632/oncotarget.3740 · Cited by 31
TORC2: a novel target for treating age-associated memory impairment
Johnson, J. L., Huang, W., Roman, G., & Costa‐Mattioli, M. (2015) · Scientific Reports · doi:10.1038/srep15193 · Cited by 31
Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury
Liu, D., Xu, L., Zhang, X., Shi, C., Qiao, S., Ma, Z., & Yuan, J. (2018) · Aging and Disease · doi:10.14336/ad.2018.0501 · Cited by 34
“, yeast, worms, flies and mammals), and mTOR pathway is responsive to changes in energy status, nutrient availability, inflammatory changes and DNA damage [21, 65-67].”
BackgroundInfluentialAntonioli, E., Torres, N., Ferretti, M., Piccinato, C. D. A., & Sertie, A. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0204784 · Cited by 35
Ageing and longevity genes in cardiovascular diseases
Liberale, L., Kraler, S. C., Camici, G. G., & Lüscher, T. F. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13426 · Cited by 34
Ionizing Radiation and Translation Control: A Link to Radiation Hormesis?
Kabilan, U., Graber, T. E., Alain, T., & Klokov, D. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186650 · Cited by 35
Malcomson, F. C., & Mathers, J. C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102710 · Cited by 36
Anti-aging activity and their mechanisms of natural food-derived peptides: current advancements
Li, J., Wang, J., Zhang, N., Li, Y., Cai, Z., Li, G., Liu, Z., Liu, Z., Wang, Y., Shao, X., et al. (2023) · Food Innovation and Advances · doi:10.48130/fia-2023-0028 · Cited by 34
Radiation-Induced Bystander Response: Mechanism and Clinical Implications
Suzuki, K., & Yamashita, S. (2013) · Advances in Wound Care · doi:10.1089/wound.2013.0468 · Cited by 35
Mood, stress and longevity: convergence on ANK3
Rangaraju, S., Levey, D. F., Nho, K. T., Jain, N., Andrews, K. D., Le-Niculescu, H., Salomon, D. R., Saykin, A. J., Petrascheck, M., & Niculescu, A. B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.65 · Cited by 33
Regulation of stem cell aging by SIRT1 – Linking metabolic signaling to epigenetic modifications
An, Y., & Dang, W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.031 · Cited by 32
Wei, Y., Reveal, B., Cai, W., & Lilly, M. A. (2016) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.035337 · Cited by 31
Metformin: From diabetes to cancer to prolongation of life
Sirtori, C. R., Castiglione, S., & Pavanello, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107367 · Cited by 38
Salminen, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102694 · Cited by 33
“This is an interesting observation because it is known that mTOR signaling inhibits autophagy and subsequently promotes the aging process (Johnson et al., 2013).”
microRNA-496 – A new, potentially aging-relevant regulator of mTOR
Rubie, C., Kölsch, K., Halajda, B., Eichler, H., Wagenpfeil, S., Roemer, K., & Glanemann, M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1158360 · Cited by 31
Liu, H., Huang, B., Xue, S., Kin Pong, U., Tsang, L. L., Zhang, X., Li, G., & Jiang, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01798-1 · Cited by 31
“Recent studies have demonstrated that prolonged activation of mTORC1 pathway is closely associated with cellular senescence and premature aging [5, 15, 30, 31].”
A ride through the epigenetic landscape: aging reversal by reprogramming
Camillo, L. P. D. L., & Quinlan, R. B. A. (2021) · GeroScience · doi:10.1007/s11357-021-00358-6 · Cited by 30
Lv, S., Liu, H., & Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136715 · Cited by 33
Cattin, M., Wang, J., Weldrick, J. J., Roeske, C. L., Mak, E., Thorn, S., DaSilva, J. N., Wang, Y., Lusis, A. J., & Burgon, P. G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678433 · Cited by 32
Rapamycin Prolongs the Survival of Corneal Epithelial Cells in Culture
Gidfar, S., Milani, F. Y., Milani, B. Y., Shen, X., Eslani, M., Putra, I., Huvard, M. J., Sagha, H. M., & Djalilian, A. R. (2017) · Scientific Reports · doi:10.1038/srep40308 · Cited by 31
Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome
Strandgren, C., Revêchon, G., Sola-Carvajal, A., & Eriksson, M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170141 · Cited by 33
Ruiz-Torres, V., Losada-Echeberría, M., Herranz‐López, M., Barrajón‐Catalán, E., Galiano, V., Micol, V., & Encinar, J. A. (2018) · Marine Drugs · doi:10.3390/md16100385 · Cited by 31
“There is still much to learn about the molecular mechanisms that lead to aging, but the implication of changes in different signaling pathways with aging, is known and includes TGF-β, p38 MAPK, JAK/STAT, Delta/Notch, PI3K, and, of course mTOR, which represents a point of interconnection between these ways [47].”
A role for TOR signaling at every stage of plant life
Quilichini, T. D., Gao, P., Pandey, P. K., Xiang, D., Ren, M., & Datla, R. (2019) · Journal of Experimental Botany · doi:10.1093/jxb/erz125 · Cited by 31
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
“Furthermore, mTOR signalling plays an evolutionarily conserved role in regulating longevity and healthspan 2, 3 .”
BackgroundXiaofei, Y., Tingting, L., Xuan, W., & Zhiyi, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043474 · Cited by 31
“As a potential treatment for age-related diseases, rapamycin shows great promise (Johnson et al., 2013; Partridge et al., 2020).”
BackgroundJang, H.-J., Yang, K. E., Oh, W. K., Lee, S.-I., Hwang, I.-H., Ban, K.-T., Yoo, H.-S., Choi, J.-S., Yeo, E.-J., & Jang, I.-S. (2019) · Aging · doi:10.18632/aging.102013 · Cited by 30
“Because mTORC1-regulated processes promote cellular aging and deactivation of the mTOR pathway slows down the aging process, the mTORC1 pathway has become a new target for anti-aging research and prevention of age-related diseases [9, 19].”
BackgroundWang, J., Zhang, M., & Wang, H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00284 · Cited by 31
Anti-Aging Effect of Traditional Plant-Based Food: An Overview
Das, G., Kameswaran, S., Ramesh, B., Manjunatha, B., Nath, R., Talukdar, A. D., Shin, H., & Patra, J. K. (2024) · Foods · doi:10.3390/foods13233785 · Cited by 34
Liu, X., Wang, G., You, Z., Qian, P., Chen, H., Dou, Y., Wei, Z., Chen, Y. X., Mao, C., & Zhang, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.009 · Cited by 29
Dysregulation of the mTOR pathway in p53-deficient mice
Leontieva, O. V., Novototskaya, L. R., Paszkiewicz, G., Komarova, E. A., Gudkov, A. V., & Blagosklonny, M. V. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26947 · Cited by 30
Cellular Aging Characteristics and Their Association with Age-Related Disorders
Rudzińska, M., Parodi, A., Balakireva, A. V., Chepikova, O. E., Venanzi, F. M., & Zamyatnin, A. A. (2020) · Antioxidants · doi:10.3390/antiox9020094 · Cited by 32
Metadata
- Authors
- Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M.
- Affiliations
- University of Washington (US)
- Guangdong Medical College (CN)
- Corresponding author
- Kaeberlein, Matt
- Venue
- Nature
- Published
- 2013-01-16
- Volume
- 493
- Issue
- 7432
- Pages
- 338-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3687363
- OpenAlex
- W2010583480
- Cited by
- 1,676
- References
- 100
- Citations by year
- 2026: 87 · 2025: 82 · 2024: 117 · 2023: 121 · 2022: 113 · 2021: 164 · 2020: 136 · 2019: 140 · 2018: 125 · 2017: 133 · 2016: 136 · 2015: 119 · 2014: 131 · 2013: 72
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031108, T32AG000057, P01AG001751, R01AG039390, R01AG038550, P30AG013280)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mTOR, aging, age-related diseases, lifespan extension, rapamycin, mTOR inhibitors, pharmacological interventions
- MeSH terms
- Aging, Animals, Humans, Insulin, Insulin-Like Growth Factor I, Longevity, Signal Transduction, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
